의료기기 판매 계약(2016-2026년)

Distribution Deals in Medical Devices 2016-2026

Understand how medical device companies structure distribution partnerships to expand commercial reach, enter new markets and bring products to healthcare customers worldwide.

Distribution Deals in Medical Devices provides comprehensive intelligence on 599 distribution deals involving medical device companies and products.

Distribution partnerships are an important route to commercialization in the medical device sector, enabling manufacturers to access established sales channels, regional expertise, healthcare customers and local market capabilities without building a complete commercial infrastructure in every territory.

The report examines both standalone distribution agreements and distribution rights incorporated within wider partnering arrangements, providing insight into the different approaches medical device companies use to commercialize products and expand geographic reach.

Rather than simply identifying transactions, the report enables users to understand who is entering distribution partnerships, how agreements are structured, which companies are particularly active, and what can be learned from disclosed financial terms and publicly available contract documents.

It provides a practical intelligence and benchmarking resource for business development, commercial strategy, market access, international business, alliance management and legal teams involved in establishing or managing medical device distribution partnerships.

Understand the medical device distribution landscape

The report analyzes distribution dealmaking from 2016 to 2026, including:

• Trends in distribution dealmaking by year
• Phase of development at the time of partnering
• Therapy area
• Technology type
• Most active distribution dealmakers
• Attributes of standalone distribution deals
• Distribution rights within multi-component agreements
• Leading deals by disclosed value
• How medical device distribution strategies are evolving
• This enables users to understand where distribution activity is concentrated and identify companies with demonstrated experience in commercializing relevant medical device products and technologies.
• Understand how medical device distribution agreements are structured
• Distribution agreements require manufacturers and their commercial partners to define territories, rights, responsibilities and the practical framework through which products will be supplied and sold.

The report provides intelligence to help users examine areas including:

• Geographic and territorial rights
• Exclusive and non-exclusive distribution
• Sales and marketing responsibilities
• Product supply arrangements
• Pricing and payment provisions
• Minimum purchase or performance commitments
• Regulatory and market access responsibilities
• Product registration and commercialization obligations
• Intellectual property and branding provisions
• Commercial responsibilities between partners
• Term and termination provisions
• Financial terms where disclosed
• The report also examines arrangements where distribution rights form part of a broader alliance, helping users understand how distribution can interact with licensing, supply, development and other partnership components.
• Identify prospective distribution partners
• For medical device companies entering new territories, identifying a distributor with relevant market presence, product expertise and commercial capabilities can be critical.
• The report identifies the Top 25 most active distribution dealmakers and provides transaction histories that can help users investigate companies with established involvement in medical device distribution.

This can support:

• Distributor and partner identification
• Assessment of potential commercial partners
• International market expansion
• Competitor analysis
• Commercialization planning
• Market-entry strategy
• Previous distribution activity can provide useful evidence of companies with an established appetite for particular device technologies, therapeutic areas and markets.
• Benchmark leading deals and disclosed financial terms
• The report identifies leading medical device distribution transactions by disclosed deal value and provides access to available financial and commercial information associated with individual agreements.
• Where terms have been disclosed, users can investigate how comparable partnerships have been structured and use these transactions as reference points when evaluating potential distribution arrangements.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying distribution contract documents.
• These agreements can reveal substantially more detail than company announcements alone, allowing users to examine how selected medical device companies have addressed issues such as territory, exclusivity, supply, pricing, minimum commitments, commercialization responsibilities and termination.
• For teams preparing for or negotiating a distribution agreement, these real-world contracts provide valuable insight into how comparable transactions have been documented in practice.
• Comprehensive medical device distribution deal directory
• The report includes a comprehensive directory of 599 medical device distribution deals, enabling users to identify transactions relevant to their own products, technologies and commercial objectives.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development teams
• Identify prospective distributors, relevant precedent transactions and comparable commercial arrangements.
• Commercial Strategy and Market Access teams
• Understand how medical device companies use distribution partnerships to extend product reach and access new markets.
• International and Regional Business teams
• Identify organizations with demonstrated medical device distribution experience and support market-entry planning.
• Medical Device Companies Seeking Commercial Partners
• Investigate potential distributors already active in related technologies, product areas and markets.
• Alliance Management teams
• Examine commercial responsibilities, supply arrangements and ongoing partner obligations within comparable agreements.
• Legal and Transaction teams
• Review agreement structures and publicly available contract language to support deal preparation and negotiation.
• Competitive and Market Intelligence teams
• Track distribution activity by company, therapy area and technology to understand evolving commercialization strategies.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying medical device distribution intelligence to the customer's own products, technologies, target markets or commercial objectives.
• Depending on requirements, this can include relevant comparable transactions, prospective distribution partners, competitor activity, commercial structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deal
• 2.3. Trends in distribution deals
  • 2.3.1. Distribution dealmaking by year
  • 2.3.2. Distribution dealmaking by phase of development
  • 2.3.3. Distribution dealmaking by therapy area
  • 2.3.4. Distribution dealmaking by technology type
  • 2.3.5. Distribution dealmaking by most active company
• 2.4. Reasons for entering into distribution partnering deals

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements
• Figure 3: Distribution deals signed at each phase of development
• Figure 4: Distribution deals by therapy area
• Figure 5: Distribution deals by technology type
• Figure 6: Top 25 most active distribution dealmakers
• Figure 7: Issues in implementing distribution agreements
• Figure 8: Distribution agreements - what should a contract include?
• Figure 9: Components of the distribution deal structure
• Figure 10: Top distribution deals by value
• Figure 11: Most active distribution dealmakers